Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0595921 (intraocular pressure)
11,750 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Fifty patients (25 per group) with the signs and symptoms of allergic conjunctivitis confirmed by positive skin test enrolled in this randomized, double-blind, parallel group, 2-week comparison of pentigetide, 0.5%, ophthalmic solution (Pentyde) and cromolyn sodium, 4%, USP ophthalmic solution (Opticrom). The physician and the patient rated the patient's overall ocular condition on days 3, 8, and 15. On day 15 both the physician and the patients rated the pentigetide group as significantly (Chi-square, P less than .05) more improved than the cromolyn sodium group. The physician rated independently conjunctival symptoms and ocular signs at days 1, 3, 8, and 15. Improvement in signs and symptoms favored pentigetide in the majority of comparisons to cromolyn sodium (14 of 18). The pentigetide group showed significantly (ANOVA, P less than .05) greater improvement in hyperemia, edema, lacrimation, and blurred vision/photophobia. Patients completed daily diaries for seven symptoms. At the end of the study, comparisons to baseline between groups favored the pentigetide group for six of the seven symptoms; for itching, improvement favored significantly (ANOVA, P less than .05) the pentigetide group. The mean severity of all symptoms decreased by 64% in the pentigetide group as compared with a decrease of 46% in the cromolyn sodium group. Adverse experiences were minor and comparable in both groups. No clinically abnormal changes were noted for visual acuity, intraocular pressure, or common laboratory tests. This double-blind, active-controlled trial demonstrates that pentigetide, 0.5%, ophthalmic solution is safe and effective in the treatment of allergic conjunctivitis.
...
PMID:Double-blind trial of pentigetide ophthalmic solution, 0.5%, compared with cromolyn sodium, 4%, ophthalmic solution for allergic conjunctivitis. 190 16

We constructed a monkey chair specially designed for ophthalmic examinations such as biomicroscopic examination, applanation tonometry etc. It was made of stainless steel and acrylic plastic, equipped with a protection plate for the experimenter, and adjustable to the size of the monkey. Using this chair, intraocular pressure (IOP) measurements of a fully conscious cynomolgus monkey were carried out at intervals of one or two hours from 10:00 AM to 10:00 PM. The IOP, at 6:00, 8:00 or 10:00 PM was compared with the IOP measured at the same time of the day after one or two weeks. The IOP while fully conscious showed diurnal variation (p < 0.001, ANOVA). The IOP measured at the same time of the day at one or two week intervals showed reasonable reproducibility.
...
PMID:[A monkey chair specially designed for ophthalmic examinations and intraocular pressure measurement in the conscious cynomolgus monkey]. 874 33

The aim of our study was to evaluate the performance of both the Keeler Pulsair 2000 and the American Optical (AO) MkII non-contact tonometers (NCT) and compare these to the reference Goldmann standard using the same group of patients. Forty-five patients (89 eyes) receiving medical treatment for primary open angle glaucoma had their intraocular pressure (IOP) measured with each instrument in a random order using five experienced observers. In the IOP range of the sample (6-27 mmHg) the difference between means for each tonometer was small. The Pulsair 2000 (mean = 19.06 mmHg, SD 6.28) read slightly higher than Goldmann (mean = 18.01 mmHg, SD 4.88), whereas the AO MkII read slightly lower (mean = 16.27 mmHg, SD 5.93). However, all differences were statistically significant (P < 0.001, repeat measures ANOVA). Correlation coefficients for Pulsair 2000 versus Goldmann was r = 0.82 and for AO MkII versus Goldmann was r = 0.85. In addition, the repeatability for each NCT was assessed using 10 consecutive measurements on a further 10 subjects. The Pulsair 2000 showed significantly greater variation of IOP (mean SD 3.43 mmHg) than the AO MkII (mean SD 1.76 mmHg), confirming the need for taking at least four readings per eye with the Pulsair 2000. These variations are greater than that generally observed with Goldmann, and possible explanations why this occurs are discussed. In conclusion, subject to these limitations, both NCTs should be useful for measuring IOP as part of a screening protocol for glaucoma.
...
PMID:Clinical comparison of the Keeler Pulsair 2000, American Optical MkII and Goldmann applanation tonometers. 876 80

The mechanism of the ocular hypotensive effect of bunazosin hydrochloride (an alpha1-adrenergic antagonist) and the possible intermediary role of prostaglandins were studied in New Zealand albino rabbits. Aqueous flow, outflow facility and uveoscleral outflow were determined by fluorophotometry, and intraocular pressure (IOP) was measured by pneumatonometry on the fourth day of twice daily topical treatment with 0.1% bunazosin. Uveoscleral outflow was measured with a tracer infusion technique at 1 to 2 hours after one dose of 0.1% bunazosin. Total outflow facility was measured by a two-level constant-pressure infusion method before and at one hour after one dose of 0.1% bunazosin. The effect of topically applied cyclooxygenase inhibitors, including 0.25% indomethacin and 0.03% flurbiprofen, on the IOP reduction after bunazosin was evaluated. At 3 hours after the seventh consecutive dose given twice-daily, bunazosin significantly (P<0.001) reduced IOP to 13.4+/-0.8 mm Hg (mean +/- SEM) from a baseline of 19.6+/-1.1 mm Hg. Indomethacin significantly inhibited the IOP reduction after one dose of bunazosin, whereas flurbiprofen did not (repeated measures ANOVA). Bunazosin significantly increased uveoscleral outflow (P<0.05) and total outflow facility (P<0.02), but not fluorophotometric outflow facility or aqueous flow. It is concluded that, in rabbits, 0.1% bunazosin reduces IOP predominantly by increasing uveoscleral outflow. The role of prostaglandins in this effect is equivocal.
...
PMID:Bunazosin reduces intraocular pressure in rabbits by increasing uveoscleral outflow. 967 29

The effects of semotiadil, a novel benzothiazine calcium antagonist, on the retinal and optic nerve head (ONH) tissue circulation were evaluated using the noninvasive laser speckle method. In urethane-anesthetized Dutch or albino rabbits, before and up to 90 min following intravenous injection of 400 microg/kg semotiadil fumarate (semotiadil group) or vehicle (control group), normalized blur value, a quantitative index of tissue blood velocity, in the retina (NB(retina)) or ONH (NB(onh)), was serially obtained with monitoring intraocular pressure (IOP) and systemic parameters: arterial pressure, pulse rate, arterial blood gas, and body temperature. There were no significant differences in IOP and the systemic parameters except arterial pressure between semotiadil and control groups during the experiments. Arterial pressure showed an acute and transient drop during the first 5 min after semotiadil administration. The time courses of the normalized blur value were significantly different between semotiadil and control groups in the retina (P = 0.0001, repeated measures two-way ANOVA), but not in the ONH (P = 0.6724). Changes in NB(retina) from the baseline in the semotiadil group was significantly greater than those in the control group 50 min or later after the administration (P < 0.0500, Mann-Whitney test). NB(onh) showed no significant differences between the two groups except during the first few min when arterial pressure acutely decreased in the semotiadil group. In conclusion, intravenously injected semotiadil increased the tissue blood velocity in the retina, but not in the ONH. This vascular selectivity in the ocular neural tissues differs from those of other calcium antagonists, such as nicardipine.
...
PMID:Effects of semotiadil, a novel calcium antagonist, on the retina and optic nerve head circulation. 1087 20

The aim of this study was to determine whether intraocular pressure (IOP), as measured by Goldmann applanation or non-contact tonometry, shows systematic changes in patients who have undergone photorefractive keratectomy (PRK) or laser in situ keratomileusis (LASIK). IOP was measured by central Goldmann and non-contact tonometry in 54 patients pre and post-PRK, and in 43 patients pre- and post-LASIK. An interval of 12 months was allowed after surgery. Patients were selected to have one of four specific initial values of refractive error (-2.5, -5.0, -7.5 and -10.0 D). Fellow unoperated eyes were used as controls. A paired Student's t-test and a one-way ANOVA test were used for statistical analysis. After PRK and LASIK, a statistically significant decrease (p < 0.01) was observed in the IOP of the treated eyes (but not for control eyes; p > 0.01). Although the magnitude of the change increased with the attempted refractive correction, this trend was not statistically significant (p > 0.01). No statistically significant differences were found between the results obtained following the two types of surgery, although the recorded fall in IOP was smaller following LASIK (p > 0.01). The IOP measured after PRK and LASIK for myopia may be reduced because of reduced corneal thickness and curvature and, possibly, tissue softening after natural healing. The presence or absence of Bowman's membrane does not appear to be important in this context. The reduction in measured IOP following refractive surgery, by about 0.5 mmHg/D of myopic correction, needs to be remembered when possible abnormality of IOP in such patients is being considered.
...
PMID:Intraocular pressure after excimer laser myopic refractive surgery. 1139 96

OBJECTIVE: To determine the mean intraocular pressure in llamas (Lama glama) and alpacas (Lama pacos) using applanation tonometry.Animals studied: Ten llamas and 10 alpacas.Procedures: Intraocular pressure (IOP) was measured with a Tono-Pentrade mark XL (Mentor Ophthalmics, Inc., Norwell, MA, USA). Three values, with 5% variance, were recorded for each eye. Least-squares means were determined for IOP for each eye of llamas and alpacas. Controlling for age, differences between left and right eye were analyzed using ANOVA. Two age groups were established, less than 5 years and greater than 5 years. The effect of age on IOP within each group was analyzed by linear regression. Probability values of less than 0.05 were considered significant. RESULTS: Comparison of mean IOP between right (n = 20) and left eyes (n = 20), independent of species type, showed no differences in IOPs for llamas and alpacas. Mean IOP declined with increasing age in llamas and alpacas. Mean IOPs for 20 eyes in 10 llamas was 16.96 +/- 3.51 mmHg. Mean IOP for 20 eyes in 10 alpacas was 16.14 +/- 3.74 mmHg. Mean IOP for all eyes (n = 40), independent of species, was 16.55 +/- 3.55 mmHg. The range of IOP in normal llamas and alpacas within 2 SD (95% of the population) was 14.89+/-18.21 mmHg. CONCLUSIONS: There was no significant difference in IOP between alpacas and llamas. Mean IOP in both species decreased with increased age.
...
PMID:Intraocular pressure in normal llamas (Lama glama) and alpacas (Lama pacos). 1139 80

The purpose of the present study was to study the effect of a single instillation of latanoprost on the human optic nerve head (ONH) and retinal circulation. Using laser-speckle tissue blood flow analysis, normalized blur (NB; a quantitative index of tissue blood velocity) was measured every 0.125 sec at a temporal ONH site free of visible surface vessels. Measurements were averaged for 3 cardiac cycles (NB(ONH)). Color Doppler Imaging (CDI) was also used to evaluate peak systolic blood velocity (PSV), endo-diastolic velocity (EDV), and resistive index (RI) in the central retinal artery (CRA) and mean blood velocity (MV) in the central retinal vein (CRV). One drop of 0.005% latanoprost was instilled into one eye and its vehicle into the other in eleven healthy volunteers in a double-blinded manner. Measurements of bilateral NB(ONH), CDI parameters, intraocular pressure (IOP), blood pressure (BP), and pulse rate (PR) were performed before, and 45, 90, 180, and 270 min after instillation. After a single instillation of latanoprost or the vehicle, there was no significant bilateral difference throughout the experimental period. The difference in NB(ONH) between that before and at each time point of measurement (delta NB(ONH)) in the latanoprost-treated eyes was significantly higher between 45 and 270 min after instillation than that in vehicle-treated eyes (P = 0.0003 to 0.0156); ANOVA for repeated measurements also revealed significant difference between both eyes (P < 0.00001). BP, PR, and NB(ONH) in the eye that received only the vehicle, PSV, EDV, and RI in the CRA in both eyes, and MV in the CRV in both eyes changed little. Tissue blood velocity in the ONH increased at least temporarily following a single instillation of topical latanoprost. Although the mechanism of the increase is unclear, the effects of latanoprost on ONH tissue circulation in humans may have clinical implications.
...
PMID:Topical latanoprost and optic nerve head and retinal circulation in humans. 1176 45

BACKGROUND: Pulsatile ocular blood flow (POBF) measurement is a new parameter to aid the understanding of the aetiology of low-tension glaucoma. There has been one study reporting the diurnal variation of POBF. However, that study involved eight subjects only. This study investigated the daytime variation of POBF with a greater sample size. METHODS: Twenty-four young Chinese subjects (12 males and 12 females) were recruited. The mean age of our subjects was 23.6 years and only the right eye was analysed. All the subjects were screened for glaucoma and the POBF was measured at three-hourly intervals from 9:00 am to 9:00 pm with an OBF tonometer (OBF Labs, UK, Ltd). The Goldmann intraocular pressure (IOP) and 'erect arm' systemic blood pressure (BP) were also measured. RESULTS: The IOP was found to be higher in the daytime, reaching the highest at noon (mean of 14.29 mmHg) and gradually reduced to the lowest at 9:00 pm (mean of 12.99 mmHg). The change was marginally significant (repeated measures ANOVA, P = 0.05). The POBF demonstrated a trend to increase from 9:00 am, mean of 605.5 &mgr;l/min, to 9:00 pm, 720.1 &mgr;l/min (repeated measures ANOVA, P < 0.01). Student-Newman-Keuls post hoc test indicated that the difference was mainly due to the comparisons between the 9:00 am and 9:00 pm results and the 9:00 am and 6:00 pm results. The pulse amplitude did not vary significantly. The mean blood pressure also demonstrated a significant variation (repeated measures ANOVA, P < 0.01). In the analysis of covariance, no significant effects of mean blood pressure on POBF and pulse amplitude were revealed. CONCLUSIONS: The variation in POBF was due to factors other than systemic blood pressure. Practitioners should consider POBF variation in repeated measurements, for example when monitoring the medical treatment for glaucoma. Further study on POBF variation is required over a complete circadian cycle.
...
PMID:Daytime variation of pulsatile ocular blood flow (POBF) in normal Chinese. 1236 14

The purpose of this study is to evaluate the effects of kallidinogenase, a tissue kallikrein, on tissue circulation in the optic nerve head (ONH), choroid and retina. Kallidinogenase (1.0 IU/kg) or saline was injected intravenously into urethane-anesthetized rabbits, and the normalized blur value (NB), a quantitative index of in vivo tissue blood velocity, was measured in the ONH, choroid and retina before and for 90 minutes after injection, using the laser speckle method. The difference in NB values in the kallidinogenase group was significantly higher compared with that in the control group in the choroid (p < 0.05) and retina (p < 0.05, ANOVA of repeated measurements). In the ONH, however, there was no significant difference between the kallidinogenase group and the control group except transient increment 10 min after drug administration (p < 0.01, unpaired t-test). On the other hand, systemic condition parameters and intraocular pressure showed no intergroup difference significantly except for a transient decrease in blood pressure and increase in pulse rate in the kallidinogenase groups. Kallidinogenase increased blood velocity, and probably blood flow, in the choroid and retina of rabbits.
...
PMID:Effects of kallidinogenase on ocular tissue circulation in rabbits. 1253 78


1 2 3 Next >>